Erratum: The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: implications for the extracorporeal purging of autologous hematopoietic stem cells (Bone Marrow Transplantation, (1997), 19, 2, (113-119), 10.1038/sj.bmt.1700625);The alkyl-lysophospholipid, ET-18-OCH3 synergistically enhances the Merocyanine 540-mediated photoinactivation of leukemia cells: Implications for the extracorporeal purging of autologous hematopoietic stem cells

Bone Marrow Transplantation

Volumn 19, Issue 2, 1997, Pages 113-119

  Yamazaki, T ^a   Sieber, F ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Alkyl lysophospholipid; Edelfosine; ET 18 OCH3; Leukemia; Marrow purging; Merocyanine 540

Indexed keywords

EDELFOSINE; MEROCYANINE; PHOTOSENSITIZING AGENT;

ANIMAL CELL; ARTICLE; AUTOTRANSPLANTATION; BONE MARROW PURGING; CELL DENSITY; CELL KILLING; CELL SURVIVAL; CONTROLLED STUDY; CRYOPRESERVATION; DRUG POTENTIATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKEMIA CELL; MACROPHAGE; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; SOLID TUMOR; STEM CELL; STEM CELL TRANSPLANTATION; TUMOR CELL;

EID: 0031032095     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1700853     Document Type: Erratum

References (66)

1. Meagher RC, Sieber F, Spivak JL. Susceptibility to merocyanine 540-mediated photosensitization: a differentiation marker on murine hematopoietic progenitor cells. J Cell Physiol 1983; 116: 118-124.
2. Sieber F, Spivak JL, Sutclitfe AM. Selective killing of leukemic cells by merocyanine 540-mediated photosensitization. Proc Natl Acad Sci SA 1984; 81: 7584-7587.
3. Sieber F, Sieber-Blum M. Dye-mediated photosensitization of murine neuroblastoma cells. Cancer Res 1986; 46: 2072-2076.
4. Sieber F, Rao S, Rowley SD, Sieber-Blum M. Dye-mediated photolysis of human neuroblastoma cells: implications for autologous bone marrow transplantation. Blood 1986; 68: 32-36.
5. Atzpodien J, Gulati SC, Clarkson BD. Comparison of the cytotoxic effects of merocyanine-540 on leukemic cells and normal human bone marrow. Cancer Res 1986; 46: 4892-4895.
6. Sieber F, Stuart RK, Rowley SD et al. Dye-mediated photolysis of normal and neoplastic hematopoietic cells. Leukemia Res 1987; 11: 43-49.
7. Porcellini A, Talevi N, Marchetti-Rossi MT et al. Limiting dilution analysis for the determination of leukemic cell frequencies after bone marrow decontamination with mafosfamide or merocyanine 540. Blood 1987; 70: 1543-1549.
8. Mumcuoglu M, Weiss L, Spivak J, Slavin S. Differential killing of murine B-cell leukemia (BCL1) by photosensitization with merocyanine 540: implications for autologous bone marrow transplantation. Bone Marrow Transplant 1989; 4: 143-146.
9. Itoh T, Messner HA, Jamal N et al. Merocyanine 540-sensitized photoinactivation of high-grade non-Hodgkin's lymphoma cells: potential application in autologous bone marrow transplantation. Bone Marrow Transplant 1993; 12: 191-196.
10. Andreesen R, Modolell M, Munder PG. Selective sensitivity of chronic myelogenous leukemia cell populations to alkyl-lysophospholipids. Blood 1979; 54: 519-523.
11. Glasser L, Somberg LB, Vogler WR. Purging murine leukemic marrow with alkyl-lysophospholipids. Blood 1984; 64: 1288-1291.
12. Okamoto S, Olson AC, Vogler WR. Elimination of leukemic cells by the combined use of ether lipids in vitro. Cancer Res 1987; 47: 2599-2603.
13. Okamoto S, Olsen AC, Berdel WE. Vogler WR. Purging of acute myeloid leukemic cells by ether lipids and hyperthermia. Blood 1988; 72: 1777-1783.
14. Danhauser-Riedl S. Himmelmann A, Steinhauser G et al. Cytotoxic effects of hexadecylphosphocholine in neoplastic cell lines including drug-resistant sublines in vitro. J Lipid Med 1990; 2: 271-280.
15. Vogler WR, Olson AC, Okamoto S et al. Comparison of selective cytotoxicity of alkyl lysophospholipids. Lipids 1991; 26: 1418-1423.
16. Dietzfelbinger HF. Lang A, Oberberg D et al. Differential cytotoxicity of an ether lipid on lymphoma and bone marrow cells and its role in purging malignant lymphoid cells from remission bone marrow contaminated with tumor cells. Exp Hematol 1992; 20: 178-183.
17. Dietzfelbinger HF, Kuhn D, Zafferani M et al. Removal of breast cancer cells from bone marrow by in vitro purging with ether lipids and cryopreservation. Cancer Res 1993; 53: 3747-3751.
18. Vogler WR. Bone marrow purging in acute leukemia with alkyl-lysophospholipids: a new family of anticancer drugs. Leuk Lymphoma 1994; 13: 53-60.
19. Sieber F, Craig A, Krueger GJ et al. Autotransplantation of bone marrow after extracorporeal purging with merocyanine 540 and light. Blood 1986; 68: 292a (Abstr.).
20. Sieber F. Extracorporeal purging of bone marrow grafts by dye-sensitized photoirrudiation. In: Gee AP (ed). Bone Marrow Processing and Purging: A Practical Guide. CRC Press: Boca Raton, 1991, pp 263-280.
21. Vogler WR, Berdel WE, Olson AC et al. Autologous bone marrow transplantation in acute leukemia with marrow purged with alkyl-lysophospholipid. Blood 1992; 80: 1423-1429.
22. Valinsky JE, Easton TG, Reich E. Merocyanine 540 as a fluorescent probe of membranes: selective staining of leukemic and immature hemopoietic cells. Cell 1978; 13: 487-499.
23. Gaffney DK, Schober SL, Sieber F. Merocyanine 540-sensitized photoinactivation of leukemia cells: role of oxygen and effects on plasma membrane integrity and mitochondrial respiration. Exp Hematol 1990; 18: 23-26.
24. Gaffney DK, Sieber F. Merocyanine 540-sensitized photoinactivation of soluble and membrane-bound enzymes in L1210 leukemia cells. Cancer Res 1990; 50: 7765-7769.
25. Smith OM, Traul DL, Sieber F. Photodamaging effects of merocyanine 540 on neutrophils and HL-60 cells. Exp Hematol 1992; 20: 1278-1284.
26. Kosano H, Takatani O. Reduction of epidermal growth factor binding in human breast cancer cell lines by an alkyl-lysophospholipid. Cancer Res 1988; 48: 6033-6036.
27. Kosano H, Takatani O. Inhibition by an alkyl-lysophospholipid of the uptake of epidermal growth factor in human breast cancer cell lines in relation to epidermal growth factor internalization. Cancer Res 1989; 49: 2868-2870.
28. Kosano H, Yasutomo Y, Kugao N et al. Inhibition of estradiol uptake and transforming growth factor alpha secretion in human breast cancer cell line MCF-7 by an alkyl-lysophospholipid. Cancer Res 1990; 50: 3172-3175.
29. Bazill GW, Dexter TM. Role of endocytosis in the action of ether lipids on WEHI-3B, HL60, and FDCP-mix A4 cells. Cancer Res 1990; 50: 7505-7512.
30. Kosano H, Takatani O. Increase of transferrin binding induced by an alkyl-lysophospholipid in breast cancer cells. J Lipid Med 1990; 2: 117-121.
31. Hoffman DR, Thomas VL, Snyder F. Inhibition of cellular transport systems by alkyl phospholipid analogs in HL-60 human leukemia cells. Biochim Biophys Acta 1992; 1127: 74-80.
32. Kelley EE, Modest EJ, Burns CP. Unidirectional membrane uptake of the ether lipid antineoplastic agent edelfosine by L1210 cells. Biochem Pharmacol 1993; 45: 2435-2439.
33. Shoji M, Fukuhara T, Winton EF et al. Different mechanisms of inhibition by alkyl-lysophospholipid and phorbol ester of granulocyte-macrophage colony-stimulating factor binding to human leukemic cell lines. Exp Hematol 1994; 22: 13-18.
34. Kalyanaraman B, Feix JB. Sieber F et al. Photodynamic action of merocyanine 540 on artificial and natural cell membranes: involvement of singlet molecular oxygen. Proc Natl Acad Sci USA 1987; 84: 2999-3003.
35. O'Brien JM, Singh RJ, Feix JB et al. Action spectra of the antileukemic and antiviral activities of merocyanine 540. Photochem Photobiol 1991; 54: 851-854.
36. Wagner BA, Buettner GR, Burns CP. Increased generation of lipid-derived and ascorbate free radicals by L1210 cells exposed to the ether lipid edelfosine. Cancer Res 1993; 53: 711-713.
37. 3 and BM 41.440. Biochem Biophys Res Commun 1988; 157: 1000-1006.
38. Grunicke H, Hofmann J, Maly K et al. The phospholipid-and calcium-dependent protein kinase as a target in tumor chemo-therapy. Adv Enz Regul 1989; 28: 201-216.
39. 2+ signaling by antitumor ether lipid analogues. Cancer Res 1990; 50: 4458-4463.
40. Shoji M, Raynor RL, Fleer EA et al. Effects of hexadecylphosphocholine on protein kinase C and TPA-induced differentiation of HL60 cells. Lipids 1991; 26: 145-149.
41. 3 acts as an activator of protein kinase C in HL-60 cells. FEBS Lett 1991; 290: 231-234.
42. Lu X, Arthur G. Perturbations of cellular acylation processes by the synthetic alkyl-lysophospholipid 1-O-octadecyl-2-O-methylglycero-3-phosphocholine do not correlate with inhibition of proliferation of MCF7 and T84 cell lines. Cancer Res 1991; 52: 2806-2812.
43. Powis G, Seewald MJ, Gratas C et al. Selective inhibition of phosphatidylinositol phospholipase C by cytotoxic ether lipid analogues. Cancer Res 1992; 52: 2835-2840.
44. Berggren MI, Gallegos A, Dressler LA et al. Inhibition of the signalling enzyme phosphatidylinositol-3-kinase by antitumor ether lipid analogues. Cancer Res 1993; 53: 4297-4302.
45. Heesbeen EC, Verdonck LF, Staal GE, Rijksen G. Protein kinase C is not involved in the cytotoxic action of 1-octadecyl-2-O-methyl-sn-glycerol-3-phosphocholine in HL-60 and K562 cells. Biochem Pharmacol 1994; 47: 1481-1488.
46. Berkovic D, Berkovic K, Fleer EA et al. Inhibition of calcium-dependent protein kinase C by hexadecylphosphocholine and 1 -O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine do not correlate with inhibition of proliferation of HL60 and K562 cell lines. Eur J Cancer 1994: 30A: 509-515.
47. Mollinedo F, Gajate C, Modolell M. The ether lipid 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine induces expression of fos and jun proto-oncogenes and activates AP-1 transcription factor in human leukaemic cells. Biochem J 1994; 302: 325-329.
48. Boggs KP, Rock CO, Jackowski S. Lysophosphatidylcholine attenuates the cytotoxic effects of the antineoplastic phospholipid 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. J Biol Chem 1995; 270: 11612-11618.
49. Traul DL, Smith OM, Sieber F. Effects of merocyanine 540-sensitized photoirradiation on cation homeostasis in L1210 leukemia and A549 lung cracinoma cells. Exp Hematol 1992; 20: 730 (Abstr.).
50. Mollinedo F, Martinez-Dalmau R, Modolell M. Early and selective induction of apoptosis in human leukemic cells by the alkyl-lysophospholipid ET-18-OCH3. Biochem Biophys Res Commun 1993; 192: 603-609.
51. Diomede L, Piovani B, Re F et al. The induction of apoptosis is a common feature of the cytotoxic action of ether-linked glycerophospholipids in human leukemic cells. Int J Cancer 1994; 57: 645-649.
52. Traul DL, Sieber F. Induction of apoptosis and necrosis in leukemia and solid tumor cells by merocyanine 540-mediated PDT. Photochem Photobiol 1994; 59: 72S (Abstr.).
53. Smith OM, Gaffney DK. Anderson MS et al. Plasma membrane properties regulating the sensitivity of leukemia, lymphoma, and solid tumor cells to merocyanine 540-sensitized photoirradiation. Exp Hematol 1991; 19: 785-788.
54. Yamazaki T, Sieber F. Role of cytoprotective mechanisms in the merocyanine 540-sensitized photoinactivation of leukemia and normal hematopoietic stem cells. Proc Am Assoc Cancer Res 1994; 35: 644 (Abstr.).
55. Sieber F, Gaffney DK, Yamazaki T, Qiu K. Importance of cellular defense mechanisms in the photodynamic purging of autologous bone marrow grafts. In: Gross S, Gee AP, Worthington-White D (eds). Advances in Bone Marrow Purging and Processing: Fourth International Symposium. Wiley-Liss: New York, 1994, pp 147-154.
56. Williamson P, Mattocks K, Schlegel RA. Merocyanine 540, a fluorescent probe sensitive to lipid packing. Biochim Biophys Acta 1983; 732: 387-393.
57. Humphries GM, Lovejoy JP. Cholesterol-free phospholipid domains may be the membrane feature selected by N-epsilondansyl-L-lysine and merocyanine 540. Biochim Biophys Res Commun 1983; 111: 768-774.
58. Gaffney DK, Feix JB, Schwarz HP et al. Cholesterol content but not plasma membrane fluidity influences the suceptibility of L1210 leukemia cells to merocyanine 540-sensitized irradiation. Photochem Photobiol 1991; 54: 717-723.
59. Berdel WE, Greiner E, Fink U et al. Cytotoxicity of alkyl-lysophospholipid derivatives and low-alkyl-cleavage enzyme activities in rat brain tumor cells. Cancer Res 1983; 43: 541-545
60. Hoffman DR, Hoffman LH, Snyder F. Cytotoxicity and metabolism of alkyl phospholipid analogues in neoplastic cells. Cancer Res 1986; 46: 5803-5809.
61. Unger C, Eibl H, Kim DJ et al. Sensitivity of leukemia cell lines to cytotoxic alkyl-lysophospholipids in relation to O-alkyl cleavage enzyme activities. J Natl Cancer Inst 1987; 78: 219-222.
62. Iscove NN, Sieber F, Winterhalter KH. Erythroid colony formation in cultures of mouse and human bone marrow: analysis of the requirement for erythropoietin by gel filtration and affinity chromatography on agarose-concanavalin-A. J Cell Physiol 1974; 83: 309-320.
63. Chabot MC, Wykle RL, Modest EJ, Daniel LW. Correlation of ether lipid content of human leukemia cell lines and their susceptibility to 1-O-octadecyl-2-O-methyl-rac-glycero-3-phosphocholine. Cancer Res 1989; 49: 4441-4445.
64. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85-86.
65. Miller CB, Rowlings PA, Jones RJ et al. Autotransplants for acute myelogenous leukemia (AML): effect of purging with 4-hydroperoxycyclophosphamide (4HC). Blood 1995; 86: 100a (Abstr.).
66. Gorin NC. Marrow purging for autologous bone marrow transplantation and its role in acute myelocytic leukemia. Leukemia 1992; 6: 96-101.